secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2026-05-13T12:08:41+00:00
Accession:  0001193125-26-220656
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Whitehawk Therapeutics raises $87.5M in PIPE, extends cash runway into H2 2028
------------------------------------------------------------------------------

- Sells 4.33M shares at $3.92/share and 17.99M pre-funded warrants at $3.9199/warrant.
- PIPE includes existing investors Avoro Capital, QVT, Coastlands, KVP, ADAR1, Acuta, StemPoint, Invus, and executives.
- Expected close May 14, 2026; net proceeds for working capital and ADC pipeline advancement.
- Cash runway extended into second half of 2028.
- Lock-up agreements for executives/directors: 60 days post-closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312526220656/0001193125-26-220656-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312526220656/d854431d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-220656

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer